Copyright
©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Aug 14, 2014; 20(30): 10338-10347
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10338
Published online Aug 14, 2014. doi: 10.3748/wjg.v20.i30.10338
Ref. | Population and timeframe | n | Triple therapy (95%CI) | Sequential therapy (95%CI) | P value |
Horvath et al[49], 2012 | Children 2005-2012 | 857 | 71% (66-75) | 78% (73-82) | |
Zullo et al[50], 2013 | Adults and children 2008-2012 | 2921 | 75.8% (73.5–78.1) | 80.6% (78.5–82.7) | 0.003 |
Kate et al[51], 2013 | Adults and children 2008-2012 | 3247 | 71.4% (64-78) | 81.7% (78-85) | 0.02 |
-
Citation: Molina-Infante J, Gisbert JP. Optimizing clarithromycin-containing therapy for
Helicobacter pylori in the era of antibiotic resistance. World J Gastroenterol 2014; 20(30): 10338-10347 - URL: https://www.wjgnet.com/1007-9327/full/v20/i30/10338.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i30.10338